Technical Analysis for MTEM - Molecular Templates, Inc.

Grade Last Price % Change Price Change
F 7.59 -2.94% -0.23
MTEM closed down 4.98 percent on Monday, April 12, 2021, on approximately normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down
Historical MTEM trend table...

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish -2.94%
180 Bearish Setup Bearish Swing Setup -2.94%
Calm After Storm Range Contraction -2.94%
Lower Bollinger Band Walk Weakness -2.94%
Inside Day Range Contraction -2.94%
Wide Bands Range Expansion -2.94%
Oversold Stochastic Weakness -2.94%
Hammer Candlestick Bullish -7.78%
Stochastic Buy Signal Bullish -7.78%
Lizard Bullish Bullish Day Trade Setup -7.78%
Older End-of-Day Signals for MTEM ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 3% 16 minutes ago
Down 2 % 16 minutes ago
60 Minute Opening Range Breakdown 28 minutes ago
Down 1% about 2 hours ago
Bearish 180 Entry about 2 hours ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of immunotoxins called engineered toxin bodies for the treatment of cancer and other serious diseases. It develops MT-3724, a lead drug candidate that is in a Phase 1 clinical trial in heavily pre-treated non-Hodgkin's lymphoma patients; MT-4019, a preclinical drug candidate targeting CD38; and evofosfamide, an investigational hypoxia-activated prodrug of a bis-alkylating agent that is preferentially activated under severe hypoxic tumor conditions, a feature of many solid tumors. The company is headquartered in Austin, Texas.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Cancer Solid Tumors Treatment Of Cancer Oncology Lymphoma Cancer Treatments Chemical Elements Oxygen Serious Diseases Toxins Prodrugs Prodrug Evofosfamide Nitrogen Mustards

Is MTEM a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 18.44
52 Week Low 7.51
Average Volume 506,675
200-Day Moving Average 11.10
50-Day Moving Average 11.61
20-Day Moving Average 10.92
10-Day Moving Average 9.85
Average True Range 0.90
ADX 23.21
+DI 14.13
-DI 37.68
Chandelier Exit (Long, 3 ATRs ) 10.58
Chandelier Exit (Short, 3 ATRs ) 10.45
Upper Bollinger Band 14.34
Lower Bollinger Band 7.49
Percent B (%b) 0.05
BandWidth 62.70
MACD Line -0.92
MACD Signal Line -0.47
MACD Histogram -0.4483
Fundamentals Value
Market Cap 357.42 Million
Num Shares 45.7 Million
EPS -0.79
Price-to-Earnings (P/E) Ratio -9.91
Price-to-Sales 18.57
Price-to-Book 5.23
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 8.51
Resistance 3 (R3) 8.57 8.40 8.39
Resistance 2 (R2) 8.40 8.22 8.37 8.36
Resistance 1 (R1) 8.11 8.12 8.02 8.05 8.32
Pivot Point 7.94 7.94 7.90 7.91 7.94
Support 1 (S1) 7.65 7.76 7.57 7.59 7.32
Support 2 (S2) 7.48 7.66 7.45 7.28
Support 3 (S3) 7.19 7.48 7.25
Support 4 (S4) 7.13